Overcoming Disparities in the Diagnosis and Treatment of Early-Stage Breast Cancer

Tarah J. Ballinger, MD


July 28, 2022

Tarah J. Ballinger, MD, considers the devastating impact that racial and socioeconomic disparities have on the diagnosis and treatment of early-stage breast cancer. In terms of mortality rates, she discusses how Black women are more likely than White women to die of their breast cancer and how that was reflected in the TAILORx clinical trial.

Dr Ballinger looks at the multifactorial nature of these disparities and the notion of implicit bias in how healthcare is delivered, as well as differences by race in tumor and host biology. Instead of just noting the existence of such disparities, she wants the oncology community to move forward to directly "nullify these disparities and improve outcomes."


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.